According to the Russian Direct Investment Fund (RDIF), the Russian Sputnik V and Sputnik Light vaccines have proven to be highly effective against all variants of SARC-Cov-2
The funds will be used to scale up existing operations and launch new products
It’s a two-dose vaccine administered 28 days apart
Market demand for significant volumes and quality of biopharma products would drive continuous manufacturing technologies
The multi-target agreement covers five programmes focused on off-the-shelf vaccines for cancer and infectious disease
This agreement marks a milestone for Baidu to use its strengths in computational biology to optimize mRNA vaccine and therapy designs
Owkin builds best-in-class predictive biomedical AI models and robust data sets
The companies expect to manufacture over 80 million does of the Covid-19 vaccine in 2022
It is estimated that one-third of our country’s population has some form of these disorders
The week-long campaign received a record 17.691 pledges
Subscribe To Our Newsletter & Stay Updated
